REDD1 is essential for stress-induced synaptic loss and depressive behavior

Nature Medicine

Volumn 20, Issue 5, 2014, Pages 531-535

  Ota, Kristie T ^a   Liu, Rong Jian ^a   Voleti, Bhavya ^a   Maldonado Aviles, Jaime G ^a   Duric, Vanja ^a,b   Iwata, Masaaki ^a   Dutheil, Sophie ^a   Duman, Catharine ^a   Boikess, Steve ^c   Lewis, David A ^d   Stockmeier, Craig A ^e   DiLeone, Ralph J ^a   Rex, Christopher ^c   Aghajanian, George K ^a   Duman, Ronald S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DES MOINES UNIVERSITY   (United States)

^c Afraxis Inc   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROTEIN SERINE THREONINE KINASE INHIBITOR; REGULATED IN DEVELOPMENT AND DNA DAMAGE RESPONSES 1; UNCLASSIFIED DRUG; DDIT4 PROTEIN, HUMAN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN ATROPHY; CHRONIC UNPREDICTABLE STRESS; DEPRESSION; GENE DELETION; HUMAN; IMMUNOFLUORESCENCE; NERVE CELL PLASTICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SYNAPTOGENESIS; ANIMAL; ANXIETY DISORDER; GENETICS; MAJOR DEPRESSION; METABOLISM; MOUSE; NERVE CELL; PATHOLOGY; SIGNAL TRANSDUCTION; SYNAPSE;

ANIMALS; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; HUMANS; MICE; MULTIPROTEIN COMPLEXES; NEURONS; PREFRONTAL CORTEX; RATS; SIGNAL TRANSDUCTION; SYNAPSES; TOR SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS;

EID: 84902997661     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3513     Document Type: Article

References (31)

1. Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, K.R. & Walters, E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62, 617–627 (2005).
2. Drevets, W.C. et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824–827 (1997).
3. Rajkowska, G. et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 45, 1085–1098 (1999).
4. Kang, H.J. et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat. Med. 18, 1413–1417 (2012).
5. Radley, J.J. et al. Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex. Cereb. Cortex 16, 313–320 (2006).
6. Radley, J.J. et al. Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 125, 1–6 (2004).
7. Willner, P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90–110 (2005).
8. Izquierdo, A., Wellman, C.L. & Holmes, A. Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. J. Neurosci. 26, 5733–5738 (2006).
9. Shansky, R.M., Hamo, C., Hof, P.R., McEwen, B.S. & Morrison, J.H. Stress-induced dendritic remodeling in the prefrontal cortex is circuit specific. Cereb. Cortex 19, 2479–2484 (2009).
10. Corradetti, M.N. The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. J. Biol. Chem. 280, 9769–9772 (2005).
11. Li, N. et al. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol. Psychiatry 69, 754–761 (2011).
12. Banasr, M. et al. Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol. Psychiatry 62, 496–504 (2007).
13. Jernigan, C.S. et al. The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1774–1779 (2011).
14. Li, N. et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959–964 (2010).
15. Wang, H., Kubica, N., Ellisen, L.W., Jefferson, L.S. & Kimball, S.R. Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J. Biol. Chem. 281, 39128–39134 (2006).
16. Polman, J.A. et al. Glucocorticoids modulate the mTOR pathway in the hippocampus: differential effects depending on stress history. Endocrinology 153, 4317–4327 (2012).
17. Boersma, G., Benthem, L., van Dijk, G., Steimer, T.J. & Scheurink, A.J. Pharmacological treatment of hyperinsulineamia in rats depends on coping style. Eur. J. Pharmacol. 654, 122–127 (2011).
18. Stetler, C. & Miller, G.E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 73, 114–126 (2011).
19. Feng, Q. et al. The stress-response gene redd1 regulates dorsoventral patterning by antagonizing Wnt/β-catenin activity in zebrafish. PLoS ONE 7, e52674 (2012).
20. Shoshani, T. et al. Identification of a novel hypoxia-inducible factor 1–responsive gene, RTP801, involved in apoptosis. Mol. Cell. Biol. 22, 2283–2293 (2002).
21. Liu, R.J. & Aghajanian, G.K. Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy. Proc. Natl. Acad. Sci. USA 105, 359–364 (2008).
22. Duman, R.S. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med. 5, 11–25 (2004).
23. Hoeffer, C.A. & Klann, E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67–75 (2010).
24. Takei, N. et al. Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J. Neurosci. 24, 9760–9769 (2004).
25. Magariños, A.M. et al. Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons. Hippocampus 21, 253–264 (2011).
26. Chen, Z.-Y. et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314, 140–143 (2006).
27. Bueller, J.A. et al. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol. Psychiatry 59, 812–815 (2006).
28. Pezawas, L. et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J. Neurosci. 24, 10099–10102 (2004).
29. Szeszko, P.R. et al. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol. Psychiatry 10, 631–636 (2005).
30. Kang, H.J. et al. Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J. Neurosci. 27, 13329–13340 (2007).
31. Sibille, E., Morris, H.M., Kota, R.S. & Lewis, D.A. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int. J. Neuropsychopharmacol. 14, 721–734 (2011).